Posted on 3/14/19
EnClear Therapies Announces Seed Funding and Senior R&D Appointment
EnClear Therapies, a biotechnology company developing device-based therapies for the treatment of neurodegenerative disease, today announced that the company
Posted on 3/13/19
Blue Cross Blue Shield of Massachusetts Receives Four Awards From SQM
Blue Cross Blue Shield of Massachusetts has received three customer experience awards from Service Quality Measurement, a leading market research firm.Blue Cross is honored to receive . . .
Posted on 3/13/19
Biogen Is Next In Line With Purchase Of Gene Therapy Biotech
SummaryBiogen acquired Nightstar Therapeutics for $25.50 per share, which was worth $800 million.The move for Biogen to acquire Nightstar was for its AAV vector platform, which . . .
Posted on 3/12/19
INVO Bioscience Launches Embryology Center in the Bay Area
INVO Bioscience, Inc. (OTC: IVOB), developers of the INVOcell intravaginal culture (IVC) system, today announced the launch of its first Company-owned embryology center in the Bay . . .
Posted on 3/12/19
Synlogic Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company applying synthetic biology to probiotics to develop novel, living medicines, today reported its financial results for . . .
Posted on 3/12/19
Biogen To Sell Its Large-Scale Biologics Manufacturing Site in Hillerød, Denmark to Fujifilm
Biogen (Nasdaq: BIIB) today announced that it has entered into a share purchase agreement with FUJIFILM Corporation (Fujifilm) under which Fujifilm
Posted on 3/12/19
Corvia Medical Enters Into Agreement With Edwards Lifesciences
Corvia Medical, Inc., a privately-held company with a first-in-class structural heart device to treat heart failure, today announced it has entered into an agreement with Edwards . . .
Posted on 3/11/19
Seres Therapeutics Announces Microbiome Immuno-Oncology Focused Collaboration with AstraZeneca
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq: MCRB) today announced a three-year research collaboration with AstraZeneca. The collaboration will focus on advancing mechanistic understanding of the microbiome . . .
Posted on 3/11/19
Alcyone Lifesciences Receives Breakthrough Device Designation from U.S. FDA for the ThecaFlex DRx System
Alcyone Lifesciences, Inc., a leader in advanced technologies to treat complex neurological and oncological conditions through the company's proprietary advanced precision delivery platforms, announced today that . . .
Posted on 3/11/19
Neon Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
CAMBRIDGE, Mass., March 11, 2019 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today reported financial results for the . . .
Posted on 3/11/19
Biogen: Adding To The Pipeline
SummaryBiogen made a nice bolt-on deal to boost its pipeline with the purchase of Nightstar Therapeutics.I like such moves being made by the business as real . . .
Posted on 3/11/19
Gene Therapy M&A Has Shares Skyrocketing -- Could This Company Be Next?
Scrambling to bulk up their drug pipelines, big biopharma companies are increasingly turning to gene therapy. Gene therapies' potential to overcome genetic mutations in over 6,000 . . .
Posted on 3/11/19
Better Buy: Amgen vs. Biogen
Amgen (NASDAQ:AMGN) and Biogen (NASDAQ:BIIB) have a lot in common. They are both hugely successful biotech giants that were founded decades ago. They each have produced . . .
Posted on 3/8/19
Celgene-Bristol: Deal Or No Deal?
SummaryLarge BMY shareholders are starting to oppose its acquisition of CELG.The uncertainty of whether the deal will go through or not is driving the fall in . . .
Posted on 3/7/19
Akili and Shionogi Announce Strategic Partnership
BOSTON & OSAKA, Japan--(BUSINESS WIRE)--Akili Interactive, a leading digital medicine company creating prescription treatments for people living with cognitive dysfunction and brain-related conditions, and Shionogi & . . .
Posted on 3/7/19
Why CVS Stock Fell 12% Last Month
What happenedShares of CVS (NYSE:CVS) were slipping in February after the drugstore chain signaled that its performance in 2019 would be challenged as it absorbed its . . .
Posted on 3/7/19
Epizyme Announces Proposed Concurrent Public Offerings of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (Nasdaq: EPZM), a late-stage company developing novel epigenetic therapies, today announced that it intends to offer and sell shares of its common . . .
Posted on 3/6/19
Beam Therapeutics Secures $135 Million In Series B
Beam Therapeutics, a biotechnology company developing precision genetic medicines through base editing, today announced the successful completion of a $135 million Series B financing.
Posted on 3/6/19
Jounce Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
CAMBRIDGE, Mass., March 06, 2019 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies . . .
Posted on 3/6/19
If The Celgene Deal Fails, Who Would Buy Bristol-Myers Squibb?
SummaryBMY is planning to acquire CELG, but critics have emerged, often saying that BMY should sell itself.However, it is not clear to me that many companies . . .
Posted on 3/6/19
Mersana Therapeutics Closes Public Offering of Common Stock
CAMBRIDGE, Mass., March 05, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (Nasdaq:MRSN) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug . . .
Posted on 3/6/19
Planet Fitness Announces Development Partnership With Kohl's
Planet Fitness, Inc. (NYSE: PLNT), one of the largest and fastest-growing franchisors and operators of fitness centers in the U.S., together with Kohl's (NYSE: KSS) announced . . .
Posted on 3/5/19
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that, on March . . .
Posted on 3/5/19
SCIEX-Sponsored Award Recognizes Achievements in Digital Microfluidics
FRAMINGHAM, Mass.--(BUSINESS WIRE)--SCIEX, a global leader in life science analytical technologies, has announced that the MSB Strategic Planning Committee selected Dr. Aaron R. Wheeler, Ph.D. as . . .
Posted on 3/5/19
ReForm Biologics Announces Collaboration Agreement with Astellas Pharma
WOBURN, Mass.--(BUSINESS WIRE)--ReForm Biologics, a privately-held pharmaceutical technology company developing innovative biologic formulations to improve drug delivery and manufacturing, today announced a collaboration with Astellas Pharma . . .

